For research use only
| Cat No. | ABC-X0307C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Fibroblast |
| Species | Human |
| Host Cell | NIH/3T3 |
| Source Organ | Embryo |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human CLIP1_LTK (L650F) NIH/3T3 Cell Line supports cancer biology research focusing on CLIP1_LTK variant-induced pathway activation and tumor progression.
Human CLIP1_LTK (L650F) NIH/3T3 Cell Line is engineered to stably express the CLIP1_LTK fusion harboring the L650F mutation, supporting studies of mutation-induced oncogenic transformation and therapeutic resistance.
Target
L650F is a point mutation situated in the LTK kinase domain and may influence kinase activity or drug binding. Its role in oncogenic signaling pathways is under investigation.
AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0307C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Embryo |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | NIH/3T3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
This model is ideal for drug screening, mutation profiling, and investigation of LTK signaling alterations related to the L650F mutation.